OrfoNeuro ApS: Financial statements 2017
CVR: 37768901
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
OrfoNeuro ApS (CVR 37768901) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -7,259 and a net result of DKK -7,259. Equity in the 2017 report amounted to DKK 42,933. The solvency ratio was 47.1%.
- Gross Profit
- DKK -7,259
- Profit/Loss
- DKK -7,259
- Equity
- DKK 42,933
- Total Assets
- DKK 91,183
- Employees
- 0
Official annual report
Keep an eye on OrfoNeuro ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
OrfoNeuro ApS has published its interim report for the period June 1, 2016 – December 31, 2016.
About OrfoNeuro ApS
OrfoNeuro ApS is a Danish company of the type Anpartsselskab based in Lynge, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jens Morten Fogh. The board consists of Ulrik Spork (chair), Jens Morten Fogh and Per Toft Valstorp. The company is owned by VALSTORP & COMPANY ApS, JIMKKS Holding ApS and Claes Magnus Andersson. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -267,558 and a net result of DKK -289,729 compared with DKK -242,569 the year before. Equity in the 2025 report amounted to DKK 9,545.